view test-data/test_in/sample.gd_sap @ 18:f04f40a36cc8

Latest changes from Belinda and Cathy. Webb's updates to the Fst tools.

#{"column_names":["contig","pos","ref","rPos","trns","pep","AA1","loc","AA2","KEGG","pred","path"],"pos":2,"rPos":4,"ref":3,"dbkey":"canFam2","scaffold":1,"species":"bear","kegg_gene":10,"kegg_path":12}
Contig39_chr1_3261104_3261850	414	chr1	3261546	ENSCAFT00000000001	ENSCAFP00000000001	S	667	F	476153	probably damaging	cfa00230=Purine metabolism.cfa00500=Starch and sucrose metabolism.cfa00740=Riboflavin metabolism.cfa00760=Nicotinate and nicotinamide metabolism.cfa00770=Pantothenate and CoA biosynthesis.cfa01100=Metabolic pathways
Contig62_chr1_19011969_19012646	265	chr1	19012240	ENSCAFT00000000144	ENSCAFP00000000125	*	161	R	483960	probably damaging	N
Contig36_chr1_20102654_20103213	365	chr1	20103029	ENSCAFT00000000160	ENSCAFP00000000140	R	407	Q	610160	possibly damaging	N
Contig136_chr10_3710404_3714591	3079	chr10	3713499	ENSCAFT00000000215	ENSCAFP00000000194	T	103	P	U	benign	N
Contig36_chr1_23682012_23682647	374	chr1	23682388	ENSCAFT00000000233	ENSCAFP00000000210	N	234	S	483973	benign	N
Contig163_chr10_4573526_4574494	487	chr10	4574010	ENSCAFT00000000365	ENSCAFP00000000332	R	186	K	474414	benign	cfa00450=Selenocompound metabolism.cfa00970=Aminoacyl-tRNA biosynthesis
Contig55_chr1_40056604_40059808	2081	chr1	40058686	ENSCAFT00000000507	ENSCAFP00000000458	I	247	K	484023	possibly damaging	N
Contig17_chr1_40203628_40205630	1417	chr1	40205044	ENSCAFT00000000517	ENSCAFP00000000468	N	109	S	476233	benign	N
Contig97_chr1_44847984_44848380	285	chr1	44848272	ENSCAFT00000000674	ENSCAFP00000000618	Q	27	R	611986	benign	N
Contig214_chr10_16106753_16106969	121	chr10	16106873	ENSCAFT00000000724	ENSCAFP00000000668	A	301	T	609478	benign	N
Contig75_chr1_45731970_45732932	436	chr1	45732397	ENSCAFT00000000760	ENSCAFP00000000701	I	490	V	U	benign	N
Contig33_chr1_45614845_45617413	1835	chr1	45616685	ENSCAFT00000000760	ENSCAFP00000000701	A	4390	V	U	benign	N
Contig95_chr10_18829724_18831056	914	chr10	18830645	ENSCAFT00000000762	ENSCAFP00000000703	A	512	V	U	possibly damaging	N
Contig197_chr13_8622062_8623071	606	chr13	8622665	ENSCAFT00000001047	ENSCAFP00000000959	T	406	I	475067	possibly damaging	cfa00240=Pyrimidine metabolism.cfa00410=beta-Alanine metabolism.cfa00770=Pantothenate and CoA biosynthesis.cfa00983=Drug metabolism - other enzymes.cfa01100=Metabolic pathways
Contig243_chr10_19959210_19960069	701	chr10	19959858	ENSCAFT00000001052	ENSCAFP00000000964	E	1345	K	U	benign	N
Contig137_chr13_10622950_10624043	1039	chr13	10623979	ENSCAFT00000001063	ENSCAFP00000000975	E	10	K	481999	benign	N
Contig137_chr13_10622950_10624043	1006	chr13	10623946	ENSCAFT00000001063	ENSCAFP00000000975	R	21	C	481999	probably damaging	N
Contig115_chr12_4411478_4412322	124	chr12	4411614	ENSCAFT00000001076	ENSCAFP00000000986	R	177	H	U	benign	N
Contig150_chr12_4438230_4439944	385	chr12	4438614	ENSCAFT00000001104	ENSCAFP00000001014	Y	277	D	607591	benign	N
Contig84_chr1_52076858_52077103	80	chr1	52076943	ENSCAFT00000001141	ENSCAFP00000001046	C	147	Y	484064	benign	N
Contig29_chr13_13215547_13217183	793	chr13	13216352	ENSCAFT00000001146	ENSCAFP00000001050	P	1	R	475076	probably damaging	N
Contig251_chr10_22876556_22877097	152	chr10	22876714	ENSCAFT00000001204	ENSCAFP00000001103	E	1162	D	481203	benign	N
Contig21_chr10_22964856_22965302	202	chr10	22965058	ENSCAFT00000001219	ENSCAFP00000001115	P	6	Q	474465	benign	N
Contig199_chr12_5083018_5084534	453	chr12	5083472	ENSCAFT00000001250	ENSCAFP00000001144	I	185	T	481729.481731	benign	N.cfa04145=Phagosome.cfa04514=Cell adhesion molecules (CAMs).cfa04612=Antigen processing and presentation.cfa04672=Intestinal immune network for IgA production.cfa04940=Type I diabetes mellitus.cfa05140=Leishmaniasis.cfa05145=Toxoplasmosis.cfa05150=Staphylococcus aureus infection.cfa05152=Tuberculosis.cfa05164=Influenza A.cfa05166=HTLV-I infection.cfa05168=Herpes simplex infection.cfa05310=Asthma.cfa05320=Autoimmune thyroid disease.cfa05322=Systemic lupus erythematosus.cfa05323=Rheumatoid arthritis.cfa05330=Allograft rejection.cfa05332=Graft-versus-host disease.cfa05416=Viral myocarditis
Contig41_chr13_21629998_21630487	161	chr13	21630157	ENSCAFT00000001352	ENSCAFP00000001239	P	729	S	482026	possibly damaging	cfa00565=Ether lipid metabolism
Contig16_chr13_21786766_21788016	169	chr13	21786927	ENSCAFT00000001363	ENSCAFP00000001249	V	1142	A	475084	benign	cfa03022=Basal transcription factors
Contig60_chr1_60333035_60333884	731	chr1	60333755	ENSCAFT00000001421	ENSCAFP00000001307	V	400	I	484096	benign	N
Contig44_chr13_24555640_24556298	499	chr13	24556139	ENSCAFT00000001523	ENSCAFP00000001400	N	660	S	475088	benign	N
Contig153_chr12_5955114_5958935	2950	chr12	5958094	ENSCAFT00000001575	ENSCAFP00000001449	E	13	D	481744	benign	cfa04141=Protein processing in endoplasmic reticulum
Contig146_chr13_25076435_25077249	723	chr13	25077165	ENSCAFT00000001587	ENSCAFP00000001461	T	9	S	482035	benign	N
Contig81_chr13_25579918_25582207	874	chr13	25580772	ENSCAFT00000001597	ENSCAFP00000001469	E	62	G	609411	benign	N
Contig159_chr10_28604683_28606028	753	chr10	28605433	ENSCAFT00000002056	ENSCAFP00000001903	S	79	P	610014	benign	N
Contig30_chr11_29945215_29949829	3973	chr11	29949181	ENSCAFT00000002100	ENSCAFP00000001944	M	282	T	U	benign	N
Contig102_chr10_29039231_29041280	829	chr10	29040065	ENSCAFT00000002110	ENSCAFP00000001953	R	311	Q	481249	unknown	N
Contig187_chr1_78583588_78584279	250	chr1	78583839	ENSCAFT00000002175	ENSCAFP00000002014	K	176	R	476310	benign	N
Contig199_chr1_79234891_79237527	384	chr1	79235278	ENSCAFT00000002259	ENSCAFP00000002095	V	403	A	484151	benign	N
Contig119_chr12_12212738_12214663	1005	chr12	12213720	ENSCAFT00000002460	ENSCAFP00000002280	R	749	Q	481785	possibly damaging	N
Contig119_chr12_12212738_12214663	918	chr12	12213633	ENSCAFT00000002460	ENSCAFP00000002280	R	778	Q	481785	benign	N
Contig39_chr14_10730123_10732539	335	chr14	10730462	ENSCAFT00000002537	ENSCAFP00000002356	V	1179	E	U	benign	N
Contig41_chr1_84886710_84894794	3494	chr1	84890207	ENSCAFT00000002577	ENSCAFP00000002394	E	1089	K	484157	possibly damaging	N
Contig182_chr12_13881114_13883427	1690	chr12	13882828	ENSCAFT00000002578	ENSCAFP00000002395	S	99	G	608906	benign	N
Contig34_chr11_48151988_48152712	198	chr11	48152205	ENSCAFT00000002660	ENSCAFP00000002468	C	587	R	U	possibly damaging	N
Contig37_chr10_34118256_34119269	437	chr10	34118687	ENSCAFT00000002792	ENSCAFP00000002588	A	377	T	474523	benign	N
Contig21_chr14_16091274_16093278	716	chr14	16091997	ENSCAFT00000002849	ENSCAFP00000002642	R	126	C	475216	probably damaging	N
Contig57_chr1_90983602_90984717	559	chr1	90984158	ENSCAFT00000002999	ENSCAFP00000002781	A	226	V	U	benign	N
Contig45_chr12_15798569_15798849	141	chr12	15798709	ENSCAFT00000003163	ENSCAFP00000002938	N	342	S	474921	benign	cfa03040=Spliceosome
Contig83_chr12_17852905_17859596	2392	chr12	17855305	ENSCAFT00000003223	ENSCAFP00000002995	E	770	Q	474925	benign	N
Contig41_chr12_18725392_18725889	169	chr12	18725560	ENSCAFT00000003307	ENSCAFP00000003070	R	80	Q	609995	benign	N
Contig9_chr14_26125779_26127414	486	chr14	26126264	ENSCAFT00000003515	ENSCAFP00000003259	P	123	T	482316	benign	N
Contig132_chr1_101565951_101566612	255	chr1	101566210	ENSCAFT00000003560	ENSCAFP00000003298	L	588	F	U	unknown	N
Contig142_chr1_102093954_102094392	121	chr1	102094072	ENSCAFT00000003644	ENSCAFP00000003373	K	120	E	484216	benign	cfa00290=Valine, leucine and isoleucine biosynthesis.cfa00970=Aminoacyl-tRNA biosynthesis
Contig129_chr14_34071666_34074617	2313	chr14	34073957	ENSCAFT00000003824	ENSCAFP00000003537	T	282	I	475249	probably damaging	N
Contig147_chr14_34262125_34262938	340	chr14	34262468	ENSCAFT00000003840	ENSCAFP00000003553	I	70	V	482333	benign	N
Contig52_chr12_36031985_36035244	1237	chr12	36033208	ENSCAFT00000004092	ENSCAFP00000003784	Y	564	H	474960	benign	N
Contig176_chr1_105494865_105495258	119	chr1	105494995	ENSCAFT00000004103	ENSCAFP00000003793	A	406	V	484298	benign	N
Contig60_chr11_63130652_63131816	702	chr11	63131349	ENSCAFT00000004208	ENSCAFP00000003892	V	260	I	481637	benign	N
Contig9_chr10_53579958_53582510	688	chr10	53580646	ENSCAFT00000004253	ENSCAFP00000003937	S	191	G	100534006.100534007.474588	benign	N
Contig93_chr14_38451661_38452163	221	chr14	38451882	ENSCAFT00000004311	ENSCAFP00000003990	A	420	V	482346	benign	N
Contig70_chr12_42859511_42860010	180	chr12	42859693	ENSCAFT00000004464	ENSCAFP00000004126	P	7	S	481892	possibly damaging	N
Contig28_chr12_43447144_43449156	1136	chr12	43448279	ENSCAFT00000004511	ENSCAFP00000004169	V	582	M	481893	benign	N
Contig18_chr13_62535238_62535697	227	chr13	62535471	ENSCAFT00000004609	ENSCAFP00000004263	E	277	D	611755	benign	N
Contig282_chr1_108960925_108962235	205	chr1	108961141	ENSCAFT00000004673	ENSCAFP00000004325	A	149	V	611817	benign	N
Contig110_chr1_109196028_109197290	987	chr1	109197021	ENSCAFT00000004726	ENSCAFP00000004374	E	330	D	610047	benign	cfa00230=Purine metabolism.cfa00240=Pyrimidine metabolism.cfa01100=Metabolic pathways.cfa03030=DNA replication.cfa03410=Base excision repair.cfa03420=Nucleotide excision repair.cfa03430=Mismatch repair.cfa03440=Homologous recombination.cfa05166=HTLV-I infection
Contig89_chr11_69097905_69099099	568	chr11	69098443	ENSCAFT00000004799	ENSCAFP00000004445	E	1317	G	U	benign	N
Contig118_chr14_46155051_46155557	173	chr14	46155218	ENSCAFT00000004933	ENSCAFP00000004572	S	110	L	482382	benign	cfa04621=NOD-like receptor signaling pathway.cfa05133=Pertussis
Contig54_chr12_51910786_51912716	682	chr12	51911460	ENSCAFT00000004993	ENSCAFP00000004630	H	2889	Y	474995	benign	cfa03008=Ribosome biogenesis in eukaryotes
Contig95_chr10_67698730_67699605	267	chr10	67698997	ENSCAFT00000005126	ENSCAFP00000004751	P	45	L	U	benign	N
Contig265_chr17_3177908_3178389	332	chr17	3178241	ENSCAFT00000005142	ENSCAFP00000004763	A	306	P	606804	benign	N
Contig322_chr17_4977962_4979371	1122	chr17	4979079	ENSCAFT00000005225	ENSCAFP00000004836	T	319	I	475647	possibly damaging	N
Contig48_chr11_71453437_71456331	1725	chr11	71455160	ENSCAFT00000005323	ENSCAFP00000004927	A	226	V	U	benign	N
Contig51_chr16_4789440_4790118	484	chr16	4789915	ENSCAFT00000005467	ENSCAFP00000005065	Q	318	H	U	benign	N
Contig32_chr12_57224809_57225619	146	chr12	57224960	ENSCAFT00000005496	ENSCAFP00000005093	A	273	T	481925	benign	N
Contig6_chr14_59310933_59312532	615	chr14	59311551	ENSCAFT00000005518	ENSCAFP00000005112	Y	304	H	492302	probably damaging	cfa02010=ABC transporters.cfa04971=Gastric acid secretion.cfa04972=Pancreatic secretion.cfa04976=Bile secretion
Contig89_chr11_74391566_74395656	2856	chr11	74394408	ENSCAFT00000005653	ENSCAFP00000031395	R	450	H	403417	benign	cfa04145=Phagosome.cfa04620=Toll-like receptor signaling pathway.cfa05132=Salmonella infection.cfa05133=Pertussis.cfa05134=Legionellosis.cfa05140=Leishmaniasis.cfa05142=Chagas disease (American trypanosomiasis).cfa05144=Malaria.cfa05145=Toxoplasmosis.cfa05146=Amoebiasis.cfa05152=Tuberculosis.cfa05162=Measles.cfa05164=Influenza A.cfa05323=Rheumatoid arthritis
Contig15_chr1_109713951_109714808	645	chr1	109714594	ENSCAFT00000005746	ENSCAFP00000005319	R	783	K	476410	benign	cfa00071=Fatty acid metabolism.cfa03320=PPAR signaling pathway.cfa04920=Adipocytokine signaling pathway
Contig47_chr17_11258085_11259619	360	chr17	11258455	ENSCAFT00000005749	ENSCAFP00000005322	V	778	L	610007	benign	N
Contig1_chr19_4352123_4352541	311	chr19	4352427	ENSCAFT00000005832	ENSCAFP00000005401	H	7	Y	403584	benign	cfa04060=Cytokine-cytokine receptor interaction.cfa04630=Jak-STAT signaling pathway.cfa04672=Intestinal immune network for IgA production.cfa05166=HTLV-I infection.cfa05168=Herpes simplex infection.cfa05323=Rheumatoid arthritis
Contig57_chr12_66915864_66916357	337	chr12	66916199	ENSCAFT00000005972	ENSCAFP00000005534	F	1242	L	475012	benign	N
Contig36_chr17_16182220_16182772	282	chr17	16182494	ENSCAFT00000006025	ENSCAFP00000005583	V	13	I	482980	possibly damaging	N
Contig64_chr19_15052202_15053292	240	chr19	15052443	ENSCAFT00000006114	ENSCAFP00000005658	I	175	V	483829	benign	N
Contig169_chr12_69415779_69417261	1136	chr12	69416908	ENSCAFT00000006157	ENSCAFP00000005701	D	85	N	475021	possibly damaging	N
Contig200_chr18_15803806_15804082	169	chr18	15803976	ENSCAFT00000006219	ENSCAFP00000005760	A	66	V	483261	benign	cfa04972=Pancreatic secretion.cfa04978=Mineral absorption
Contig6_chr18_15814044_15814404	97	chr18	15814150	ENSCAFT00000006219	ENSCAFP00000005760	A	413	S	483261	benign	cfa04972=Pancreatic secretion.cfa04978=Mineral absorption
Contig104_chr1_110433641_110434230	183	chr1	110433810	ENSCAFT00000006272	ENSCAFP00000005811	A	315	T	484394	benign	cfa00280=Valine, leucine and isoleucine degradation.cfa00290=Valine, leucine and isoleucine biosynthesis.cfa00770=Pantothenate and CoA biosynthesis.cfa01100=Metabolic pathways
Contig52_chr18_17851226_17851871	284	chr18	17851509	ENSCAFT00000006453	ENSCAFP00000005976	T	311	M	475893	probably damaging	N
Contig63_chr16_12167721_12168304	388	chr16	12168099	ENSCAFT00000006479	ENSCAFP00000006000	M	634	V	U	benign	N
Contig101_chr20_4702659_4703738	441	chr20	4703092	ENSCAFT00000006507	ENSCAFP00000006027	G	635	D	484622	probably damaging	cfa03030=DNA replication.cfa04110=Cell cycle
Contig53_chr19_21456428_21457881	408	chr19	21456840	ENSCAFT00000006669	ENSCAFP00000006174	R	247	L	476094	possibly damaging	N
Contig58_chr18_19883250_19884312	250	chr18	19883498	ENSCAFT00000006689	ENSCAFP00000006194	*	503	Y	475897	benign	N
Contig122_chr15_17034758_17035049	142	chr15	17034893	ENSCAFT00000006827	ENSCAFP00000006320	R	117	P	U	benign	N
Contig131_chr18_20356930_20357227	113	chr18	20357041	ENSCAFT00000006891	ENSCAFP00000006378	V	55	L	610021	benign	N
Contig117_chr22_5859195_5860740	654	chr22	5859850	ENSCAFT00000007130	ENSCAFP00000006603	S	139	N	485445	benign	cfa04020=Calcium signaling pathway.cfa04080=Neuroactive ligand-receptor interaction
Contig91_chr17_23506302_23507213	322	chr17	23506624	ENSCAFT00000007145	ENSCAFP00000006614	V	1644	I	607961	benign	N
Contig3_chr21_16586556_16586852	105	chr21	16586661	ENSCAFT00000007244	ENSCAFP00000006709	C	33	Y	476781	possibly damaging	N
Contig62_chr2_22645987_22646907	357	chr2	22646352	ENSCAFT00000007375	ENSCAFP00000006833	V	657	F	403767	probably damaging	cfa04977=Vitamin digestion and absorption
Contig52_chr15_18032498_18034281	880	chr15	18033373	ENSCAFT00000007440	ENSCAFP00000006895	P	227	A	482516	benign	N
Contig131_chr23_6679385_6679850	198	chr23	6679592	ENSCAFT00000007467	ENSCAFP00000006915	R	136	G	485576	possibly damaging	N
Contig157_chr22_10584088_10586765	232	chr22	10584326	ENSCAFT00000007484	ENSCAFP00000006926	M	610	T	609336	benign	N
Contig164_chr2_24336024_24340161	2420	chr2	24338436	ENSCAFT00000007527	ENSCAFP00000006969	S	824	C	607108	probably damaging	N
Contig109_chr2_24557417_24558710	808	chr2	24558229	ENSCAFT00000007553	ENSCAFP00000006994	L	606	V	487123	benign	cfa03450=Non-homologous end-joining.cfa05340=Primary immunodeficiency
Contig194_chr15_18573761_18574204	142	chr15	18573904	ENSCAFT00000007697	ENSCAFP00000007130	V	381	I	475382	benign	N
Contig133_chr23_9924894_9925887	125	chr23	9925016	ENSCAFT00000007703	ENSCAFP00000007136	P	355	S	477019	benign	cfa03430=Mismatch repair.cfa03460=Fanconi anemia pathway.cfa05200=Pathways in cancer.cfa05210=Colorectal cancer.cfa05213=Endometrial cancer
Contig31_chr23_10199273_10203629	4073	chr23	10203350	ENSCAFT00000007747	ENSCAFP00000007179	A	1844	V	U	benign	N
Contig21_chr23_10308212_10309269	513	chr23	10308732	ENSCAFT00000007774	ENSCAFP00000007206	K	72	R	477021	benign	cfa04510=Focal adhesion.cfa04512=ECM-receptor interaction.cfa04514=Cell adhesion molecules (CAMs).cfa04810=Regulation of actin cytoskeleton.cfa05410=Hypertrophic cardiomyopathy (HCM).cfa05412=Arrhythmogenic right ventricular cardiomyopathy (ARVC).cfa05414=Dilated cardiomyopathy
Contig211_chr1_114924893_114925515	171	chr1	114925067	ENSCAFT00000007776	ENSCAFP00000007208	P	1988	A	U	benign	N
Contig35_chr2_27160577_27161526	804	chr2	27161367	ENSCAFT00000007779	ENSCAFP00000007211	G	473	R	478007.478008	probably damaging	cfa03060=Protein export.cfa04141=Protein processing in endoplasmic reticulum.cfa04145=Phagosome
Contig79_chr17_24285444_24286769	1263	chr17	24286694	ENSCAFT00000007859	ENSCAFP00000007285	S	209	T	483010	benign	N
Contig74_chr23_10871047_10871362	70	chr23	10871116	ENSCAFT00000007951	ENSCAFP00000007365	I	474	V	U	benign	N
Contig34_chr16_18928689_18932806	3409	chr16	18932072	ENSCAFT00000007959	ENSCAFP00000007370	A	3754	S	482810.611087	benign	cfa00310=Lysine degradation
Contig52_chr21_24452521_24454405	725	chr21	24453245	ENSCAFT00000008012	ENSCAFP00000007418	M	289	T	485173	possibly damaging	N
Contig261_chr1_115563599_115564561	560	chr1	115564156	ENSCAFT00000008063	ENSCAFP00000007465	A	63	T	484489	possibly damaging	N
Contig62_chr19_41037398_41039465	159	chr19	41037564	ENSCAFT00000008142	ENSCAFP00000007541	C	744	Y	476128	possibly damaging	N
Contig84_chr1_115960693_115962811	1467	chr1	115962120	ENSCAFT00000008198	ENSCAFP00000007593	W	61	R	612489	benign	N
Contig135_chr23_14160194_14160717	270	chr23	14160468	ENSCAFT00000008413	ENSCAFP00000007796	V	298	I	U	benign	N
Contig41_chr17_26203621_26205196	1407	chr17	26205028	ENSCAFT00000008540	ENSCAFP00000007913	H	172	R	483021	benign	N
Contig260_chr1_116076701_116078120	746	chr1	116077446	ENSCAFT00000008586	ENSCAFP00000007956	T	2486	I	484499	benign	N
Contig19_chr23_14811332_14815323	1987	chr23	14813327	ENSCAFT00000008588	ENSCAFP00000007958	S	690	L	U	unknown	N
Contig180_chr2_35061773_35062172	166	chr2	35061941	ENSCAFT00000008673	ENSCAFP00000008039	T	920	M	478018	probably damaging	N
Contig106_chr21_26153874_26154496	107	chr21	26153984	ENSCAFT00000008678	ENSCAFP00000008044	A	458	T	485188	benign	N
Contig3_chr19_45625337_45630123	2563	chr19	45627887	ENSCAFT00000008728	ENSCAFP00000008094	V	1264	I	U	benign	N
Contig51_chr22_48760401_48761638	636	chr22	48761047	ENSCAFT00000008769	ENSCAFP00000008132	R	1071	K	485523	benign	cfa02010=ABC transporters.cfa04976=Bile secretion
Contig10_chr15_21173640_21174011	212	chr15	21173839	ENSCAFT00000008831	ENSCAFP00000008192	V	191	I	475398	benign	N
Contig6_chr24_14680423_14681438	782	chr24	14681208	ENSCAFT00000009074	ENSCAFP00000008417	H	562	R	485769	possibly damaging	cfa04330=Notch signaling pathway
Contig60_chr9_4528464_4529207	262	chr9	4528727	ENSCAFT00000009114	ENSCAFP00000008453	C	24	F	483354	possibly damaging	N
Contig54_chr15_29510545_29512205	400	chr15	29510955	ENSCAFT00000009614	ENSCAFP00000008928	H	190	R	475416	benign	N
Contig46_chr25_5067588_5068089	39	chr25	5067627	ENSCAFT00000009698	ENSCAFP00000009003	S	17	N	486001	benign	N
Contig126_chr25_5114359_5115799	643	chr25	5114996	ENSCAFT00000009710	ENSCAFP00000009013	R	1952	C	486002	possibly damaging	N
Contig41_chr26_3455305_3455893	329	chr26	3455620	ENSCAFT00000010094	ENSCAFP00000009363	S	909	A	486223	benign	cfa00230=Purine metabolism.cfa00240=Pyrimidine metabolism.cfa01100=Metabolic pathways.cfa03030=DNA replication.cfa03410=Base excision repair.cfa03420=Nucleotide excision repair.cfa05166=HTLV-I infection
Contig55_chr26_3463883_3465235	1074	chr26	3464998	ENSCAFT00000010094	ENSCAFP00000009363	R	1273	S	486223	benign	cfa00230=Purine metabolism.cfa00240=Pyrimidine metabolism.cfa01100=Metabolic pathways.cfa03030=DNA replication.cfa03410=Base excision repair.cfa03420=Nucleotide excision repair.cfa05166=HTLV-I infection
Contig63_chr26_3467460_3468420	195	chr26	3467661	ENSCAFT00000010094	ENSCAFP00000009363	E	1542	Q	486223	benign	cfa00230=Purine metabolism.cfa00240=Pyrimidine metabolism.cfa01100=Metabolic pathways.cfa03030=DNA replication.cfa03410=Base excision repair.cfa03420=Nucleotide excision repair.cfa05166=HTLV-I infection
Contig13_chr16_32259141_32259752	344	chr16	32259472	ENSCAFT00000010141	ENSCAFP00000009407	I	326	T	482857	benign	cfa04360=Axon guidance
Contig59_chr21_32994329_32995926	1195	chr21	32995538	ENSCAFT00000010439	ENSCAFP00000009680	H	230	R	610992	benign	N
Contig39_chr20_24938452_24941620	1292	chr20	24939734	ENSCAFT00000010496	ENSCAFP00000009730	S	28	P	415126	benign	cfa04380=Osteoclast differentiation.cfa04916=Melanogenesis.cfa05200=Pathways in cancer.cfa05218=Melanoma
Contig2_chr18_28546360_28546760	277	chr18	28546640	ENSCAFT00000010516	ENSCAFP00000009748	P	471	S	U	benign	N
Contig23_chr20_25560598_25562858	928	chr20	25561520	ENSCAFT00000010531	ENSCAFP00000009762	T	749	I	484693	benign	N
Contig209_chr18_28672330_28672791	376	chr18	28672689	ENSCAFT00000010559	ENSCAFP00000009790	A	33	D	483405	unknown	N
Contig261_chr18_28694652_28696968	1808	chr18	28696427	ENSCAFT00000010559	ENSCAFP00000009790	P	1443	L	483405	possibly damaging	N
Contig30_chr25_12008255_12009009	151	chr25	12008417	ENSCAFT00000010593	ENSCAFP00000009822	Q	151	H	U	benign	N
Contig46_chr29_3065854_3067420	1265	chr29	3067078	ENSCAFT00000010616	ENSCAFP00000009842	V	3253	A	474176	benign	cfa03450=Non-homologous end-joining.cfa04110=Cell cycle
Contig59_chr28_3755477_3757019	935	chr28	3756419	ENSCAFT00000010630	ENSCAFP00000009853	R	923	Q	486770	possibly damaging	N
Contig90_chr29_6393993_6395503	951	chr29	6394948	ENSCAFT00000010829	ENSCAFP00000010033	Y	257	C	486944	benign	N
Contig42_chr16_39015800_39016389	319	chr16	39016119	ENSCAFT00000010865	ENSCAFP00000010068	D	71	N	U	possibly damaging	N
Contig95_chr21_34533214_34535079	1133	chr21	34534321	ENSCAFT00000010931	ENSCAFP00000010131	E	118	G	485368	benign	N
Contig82_chr21_34524815_34525170	247	chr21	34525072	ENSCAFT00000010931	ENSCAFP00000010131	Q	499	R	485368	benign	N
Contig32_chr24_22727492_22727986	147	chr24	22727648	ENSCAFT00000010977	ENSCAFP00000010173	P	278	L	U	possibly damaging	N
Contig45_chr16_42405571_42406148	269	chr16	42405837	ENSCAFT00000010988	ENSCAFP00000010184	H	406	R	482891	benign	cfa04145=Phagosome
Contig66_chr15_43321121_43321872	642	chr15	43321764	ENSCAFT00000011187	ENSCAFP00000010364	F	543	L	475441	benign	N
Contig184_chr27_5103641_5104991	275	chr27	5103979	ENSCAFT00000011380	ENSCAFP00000010541	V	864	A	U	benign	N
Contig88_chr17_39320200_39320765	204	chr17	39320404	ENSCAFT00000011397	ENSCAFP00000010558	S	1911	N	475750	benign	cfa04110=Cell cycle.cfa04114=Oocyte meiosis.cfa04120=Ubiquitin mediated proteolysis.cfa04914=Progesterone-mediated oocyte maturation.cfa05166=HTLV-I infection
Contig8_chr16_47195242_47195504	193	chr16	47195429	ENSCAFT00000011721	ENSCAFP00000010862	S	4369	W	475621	benign	N
Contig84_chr27_5882441_5882771	145	chr27	5882579	ENSCAFT00000011730	ENSCAFP00000010871	C	289	S	486534	benign	N
Contig42_chr24_25316755_25317362	320	chr24	25317091	ENSCAFT00000011771	ENSCAFP00000010910	G	22	S	477193	benign	N
Contig45_chr24_25318544_25319490	734	chr24	25319299	ENSCAFT00000011771	ENSCAFP00000010910	V	187	A	477193	benign	N
Contig31_chr24_25434125_25435133	853	chr24	25434975	ENSCAFT00000011789	ENSCAFP00000010928	S	91	I	609978	benign	N
Contig20_chr3_10579133_10580085	600	chr3	10579729	ENSCAFT00000011968	ENSCAFP00000011099	K	165	E	488881	benign	cfa00760=Nicotinate and nicotinamide metabolism.cfa04146=Peroxisome
Contig45_chr2_54585564_54588038	1047	chr2	54586611	ENSCAFT00000012081	ENSCAFP00000011198	T	969	M	478082	benign	cfa04621=NOD-like receptor signaling pathway
Contig156_chr1_122375741_122376035	168	chr1	122375904	ENSCAFT00000012133	ENSCAFP00000011248	R	628	K	611998	benign	N
Contig153_chr1_124036982_124040108	1588	chr1	124038585	ENSCAFT00000012159	ENSCAFP00000011272	A	887	T	484609	benign	N
Contig32_chr24_26900375_26900913	394	chr24	26900761	ENSCAFT00000012254	ENSCAFP00000011358	H	51	Y	U	benign	N
Contig103_chr16_48829082_48829675	123	chr16	48829205	ENSCAFT00000012381	ENSCAFP00000011471	E	369	G	475632	possibly damaging	N
Contig25_chr18_41490135_41493501	534	chr18	41490665	ENSCAFT00000012414	ENSCAFP00000011503	R	703	C	483489	probably damaging	cfa04520=Adherens junction.cfa04670=Leukocyte transendothelial migration
Contig69_chr16_49314879_49317228	1810	chr16	49316689	ENSCAFT00000012456	ENSCAFP00000011541	P	431	L	475636	probably damaging	cfa00565=Ether lipid metabolism
Contig71_chr17_42734055_42736474	2240	chr17	42736298	ENSCAFT00000012478	ENSCAFP00000011561	R	307	Q	483083	benign	cfa00830=Retinol metabolism
Contig17_chr17_43378842_43379885	305	chr17	43379148	ENSCAFT00000012676	ENSCAFP00000011740	T	196	M	U	probably damaging	N
Contig195_chr27_7047911_7049009	555	chr27	7048468	ENSCAFT00000012942	ENSCAFP00000011978	R	881	L	477608	benign	N
Contig112_chr30_4254316_4256576	1478	chr30	4255785	ENSCAFT00000012974	ENSCAFP00000012007	V	2939	I	U	benign	N
Contig43_chr20_39124486_39124798	114	chr20	39124607	ENSCAFT00000013097	ENSCAFP00000012118	G	325	R	607274	possibly damaging	N
Contig96_chr16_55849292_55849592	194	chr16	55849494	ENSCAFT00000013360	ENSCAFP00000012363	A	41	S	482932	benign	cfa04060=Cytokine-cytokine receptor interaction.cfa04150=mTOR signaling pathway.cfa04510=Focal adhesion.cfa05200=Pathways in cancer.cfa05211=Renal cell carcinoma.cfa05212=Pancreatic cancer.cfa05219=Bladder cancer
Contig91_chr17_51684551_51689453	4154	chr17	51688687	ENSCAFT00000013395	ENSCAFP00000012395	P	306	L	475784	benign	N
Contig192_chr26_12794366_12794712	143	chr26	12794506	ENSCAFT00000014076	ENSCAFP00000013021	V	2478	I	477486	benign	N
Contig191_chr31_30109152_30109760	212	chr31	30109363	ENSCAFT00000014113	ENSCAFP00000013055	A	1813	T	487735	probably damaging	N
Contig116_chr24_29683980_29684819	101	chr24	29684079	ENSCAFT00000014115	ENSCAFP00000013057	R	836	C	485868	probably damaging	N
Contig8_chr32_9413601_9414435	74	chr32	9413675	ENSCAFT00000014257	ENSCAFP00000013183	N	236	K	478452	probably damaging	cfa00270=Cysteine and methionine metabolism
Contig90_chr21_43253791_43254774	189	chr21	43253974	ENSCAFT00000014325	ENSCAFP00000013248	I	758	V	U	benign	N
Contig76_chr24_30292767_30294101	552	chr24	30293321	ENSCAFT00000014346	ENSCAFP00000013267	A	349	T	U	benign	N
Contig21_chr25_37121451_37122072	177	chr25	37121616	ENSCAFT00000014616	ENSCAFP00000013518	V	157	L	486118	benign	N
Contig15_chr36_6357141_6362626	5226	chr36	6362346	ENSCAFT00000014702	ENSCAFP00000013598	N	138	K	607626	possibly damaging	N
Contig64_chr17_54734453_54734993	109	chr17	54734552	ENSCAFT00000014707	ENSCAFP00000013603	S	302	L	483124	benign	N
Contig91_chr18_46134014_46136042	330	chr18	46134347	ENSCAFT00000014736	ENSCAFP00000013630	A	214	S	483635	benign	cfa00561=Glycerolipid metabolism.cfa00564=Glycerophospholipid metabolism.cfa01100=Metabolic pathways.cfa04070=Phosphatidylinositol signaling system
Contig111_chr31_31237314_31238628	920	chr31	31238220	ENSCAFT00000014822	ENSCAFP00000013714	S	143	C	478408	benign	N
Contig77_chr38_3502296_3503058	349	chr38	3502639	ENSCAFT00000015260	ENSCAFP00000014122	K	666	E	478932	benign	N
Contig59_chr38_3998294_3999004	369	chr38	3998672	ENSCAFT00000015347	ENSCAFP00000014201	V	791	I	U	benign	N
Contig123_chr31_34367825_34368648	664	chr31	34368468	ENSCAFT00000015534	ENSCAFP00000014373	H	204	Q	U	possibly damaging	N
Contig43_chr30_11874641_11875130	198	chr30	11874850	ENSCAFT00000015654	ENSCAFP00000014488	R	3422	C	U	benign	N
Contig9_chr20_40741488_40743247	1027	chr20	40742525	ENSCAFT00000015816	ENSCAFP00000014638	M	183	V	484744	benign	N
Contig137_chr5_7048977_7051042	863	chr5	7049840	ENSCAFT00000015844	ENSCAFP00000014662	A	311	V	479391	benign	N
Contig9_chr28_17675067_17680985	1564	chr28	17676618	ENSCAFT00000015971	ENSCAFP00000014772	R	515	P	477805	unknown	N
Contig126_chr30_12286682_12287475	407	chr30	12287101	ENSCAFT00000016062	ENSCAFP00000014854	V	450	I	487517	benign	cfa00052=Galactose metabolism.cfa00500=Starch and sucrose metabolism.cfa01100=Metabolic pathways
Contig127_chr30_12287497_12288447	608	chr30	12288095	ENSCAFT00000016062	ENSCAFP00000014854	T	495	M	487517	benign	cfa00052=Galactose metabolism.cfa00500=Starch and sucrose metabolism.cfa01100=Metabolic pathways
Contig13_chr38_5058391_5058630	66	chr38	5058458	ENSCAFT00000016099	ENSCAFP00000014887	F	412	L	478943	benign	N
Contig169_chr35_19985467_19986000	455	chr35	19985921	ENSCAFT00000016165	ENSCAFP00000014950	T	175	I	478733	benign	N
Contig2_chr35_21794536_21795092	291	chr35	21794865	ENSCAFT00000016208	ENSCAFP00000014992	V	84	A	488238	benign	cfa00561=Glycerolipid metabolism.cfa00564=Glycerophospholipid metabolism.cfa01100=Metabolic pathways
Contig141_chr26_19278751_19279229	364	chr26	19279128	ENSCAFT00000016284	ENSCAFP00000015064	N	29	S	404011	benign	cfa00564=Glycerophospholipid metabolism.cfa00565=Ether lipid metabolism.cfa00590=Arachidonic acid metabolism.cfa00591=Linoleic acid metabolism.cfa00592=alpha-Linolenic acid metabolism.cfa01100=Metabolic pathways.cfa04010=MAPK signaling pathway.cfa04270=Vascular smooth muscle contraction.cfa04370=VEGF signaling pathway.cfa04664=Fc epsilon RI signaling pathway.cfa04724=Glutamatergic synapse.cfa04730=Long-term depression.cfa04912=GnRH signaling pathway.cfa04972=Pancreatic secretion.cfa04975=Fat digestion and absorption.cfa05145=Toxoplasmosis
Contig179_chr3_40781459_40782026	285	chr3	40781763	ENSCAFT00000016410	ENSCAFP00000015182	D	1174	N	488699	benign	N
Contig237_chr21_53631024_53632458	203	chr21	53631227	ENSCAFT00000016459	ENSCAFP00000015227	C	47	W	403799	probably damaging	cfa04664=Fc epsilon RI signaling pathway.cfa05310=Asthma
Contig186_chr2_71203100_71204111	202	chr2	71203303	ENSCAFT00000016485	ENSCAFP00000015250	S	188	T	478144	benign	cfa00330=Arginine and proline metabolism.cfa01100=Metabolic pathways
Contig1_chr28_18779291_18780149	325	chr28	18779619	ENSCAFT00000016578	ENSCAFP00000015340	N	245	Y	U	probably damaging	N
Contig166_chr4_77425871_77426835	797	chr4	77426667	ENSCAFT00000016670	ENSCAFP00000015429	D	115	G	479370	benign	cfa00970=Aminoacyl-tRNA biosynthesis
Contig35_chr24_36806524_36807086	367	chr24	36806891	ENSCAFT00000016727	ENSCAFP00000015478	F	345	L	485910	benign	N
Contig45_chr37_8610877_8611425	194	chr37	8611078	ENSCAFT00000016761	ENSCAFP00000015511	D	2849	N	488452	possibly damaging	N
Contig39_chr28_19446540_19447838	1068	chr28	19447566	ENSCAFT00000016791	ENSCAFP00000015537	A	1596	E	U	benign	N
Contig161_chr18_51013230_51015381	1494	chr18	51014735	ENSCAFT00000016827	ENSCAFP00000015571	L	977	V	475999	benign	N
Contig25_chr28_19619108_19621267	1728	chr28	19620832	ENSCAFT00000016848	ENSCAFP00000034237	I	108	V	609723	benign	N
Contig33_chr20_42063173_42064259	623	chr20	42063789	ENSCAFT00000017070	ENSCAFP00000015794	V	179	M	U	probably damaging	N
Contig39_chr38_14681397_14682234	384	chr38	14681781	ENSCAFT00000017072	ENSCAFP00000015796	H	282	N	488593	unknown	N
Contig6_chr32_27303975_27304541	425	chr32	27304407	ENSCAFT00000017178	ENSCAFP00000015896	S	354	T	610098	benign	N
Contig173_chr38_17709765_17711029	179	chr38	17709941	ENSCAFT00000017240	ENSCAFP00000015955	G	464	R	U	benign	N
Contig52_chr32_27452924_27453332	91	chr32	27452999	ENSCAFT00000017249	ENSCAFP00000015964	A	22	S	U	benign	N
Contig319_chr34_14684259_14684663	353	chr34	14684613	ENSCAFT00000017314	ENSCAFP00000016025	R	5	Q	478632	benign	N
Contig32_chr2_72269353_72269814	349	chr2	72269708	ENSCAFT00000017327	ENSCAFP00000016037	P	853	L	487317	possibly damaging	N
Contig206_chr9_18720001_18720613	155	chr9	18720160	ENSCAFT00000017373	ENSCAFP00000016082	D	1621	E	480456	benign	cfa02010=ABC transporters
Contig35_chr37_10562149_10562621	74	chr37	10562222	ENSCAFT00000017444	ENSCAFP00000016153	I	975	V	478858	benign	cfa04727=GABAergic synapse
Contig1_chr30_12655575_12656916	370	chr30	12655947	ENSCAFT00000017777	ENSCAFP00000016457	L	639	M	608886	probably damaging	N
Contig63_chr27_23738716_23739879	1131	chr27	23739850	ENSCAFT00000017892	ENSCAFP00000016566	P	642	L	486627	benign	N
Contig44_chr28_28123120_28124627	1348	chr28	28124495	ENSCAFT00000017967	ENSCAFP00000016639	V	261	A	477827	benign	N
Contig23_chrX_6416128_6417014	455	chrX	6416585	ENSCAFT00000018017	ENSCAFP00000016684	H	111	R	491733	possibly damaging	N
Contig31_chr7_8282189_8286932	3631	chr7	8285875	ENSCAFT00000018057	ENSCAFP00000016724	L	655	P	490260	benign	N
Contig318_chr6_8706066_8706350	76	chr6	8706142	ENSCAFT00000018106	ENSCAFP00000016769	K	318	N	607700	possibly damaging	cfa04062=Chemokine signaling pathway.cfa04145=Phagosome.cfa04380=Osteoclast differentiation.cfa04666=Fc gamma R-mediated phagocytosis.cfa04670=Leukocyte transendothelial migration.cfa05140=Leishmaniasis
Contig36_chr32_33046881_33048369	1118	chr32	33047990	ENSCAFT00000018307	ENSCAFP00000016954	E	555	A	403657	benign	cfa04010=MAPK signaling pathway.cfa04012=ErbB signaling pathway.cfa04060=Cytokine-cytokine receptor interaction.cfa04144=Endocytosis.cfa04510=Focal adhesion.cfa04540=Gap junction.cfa04810=Regulation of actin cytoskeleton.cfa05160=Hepatitis C.cfa05200=Pathways in cancer.cfa05212=Pancreatic cancer.cfa05213=Endometrial cancer.cfa05214=Glioma.cfa05215=Prostate cancer.cfa05218=Melanoma.cfa05219=Bladder cancer.cfa05223=Non-small cell lung cancer
Contig32_chr5_14476595_14477214	347	chr5	14476948	ENSCAFT00000018571	ENSCAFP00000017201	V	209	A	610296	benign	N
Contig88_chr34_19031138_19031937	343	chr34	19031477	ENSCAFT00000018684	ENSCAFP00000017309	K	670	R	478645	benign	cfa00280=Valine, leucine and isoleucine degradation.cfa01100=Metabolic pathways
Contig188_chr25_47927372_47928085	557	chr25	47927941	ENSCAFT00000018758	ENSCAFP00000017379	K	228	R	486167	benign	cfa00561=Glycerolipid metabolism.cfa00564=Glycerophospholipid metabolism.cfa01100=Metabolic pathways.cfa04070=Phosphatidylinositol signaling system
Contig36_chr37_12924359_12924740	86	chr37	12924449	ENSCAFT00000018786	ENSCAFP00000017406	D	187	Y	608849	probably damaging	cfa00280=Valine, leucine and isoleucine degradation.cfa00350=Tyrosine metabolism.cfa00380=Tryptophan metabolism.cfa00750=Vitamin B6 metabolism.cfa00760=Nicotinate and nicotinamide metabolism.cfa00982=Drug metabolism - cytochrome P450.cfa01100=Metabolic pathways
Contig3_chr34_19471626_19472377	337	chr34	19471956	ENSCAFT00000018788	ENSCAFP00000017408	R	239	Q	488096	possibly damaging	N
Contig80_chr4_11155760_11156827	952	chr4	11156735	ENSCAFT00000018796	ENSCAFP00000017416	S	661	N	479204	benign	cfa00564=Glycerophospholipid metabolism.cfa04146=Peroxisome
Contig56_chr8_7093747_7095987	683	chr8	7094428	ENSCAFT00000018813	ENSCAFP00000017431	P	126	R	490620	unknown	N
Contig82_chr8_7111986_7114065	1351	chr8	7113329	ENSCAFT00000018871	ENSCAFP00000017488	R	608	H	480255	probably damaging	cfa00010=Glycolysis / Gluconeogenesis.cfa00020=Citrate cycle (TCA cycle).cfa00620=Pyruvate metabolism.cfa01100=Metabolic pathways.cfa03320=PPAR signaling pathway.cfa04910=Insulin signaling pathway.cfa04920=Adipocytokine signaling pathway.cfa04964=Proximal tubule bicarbonate reclamation
Contig172_chr33_28585454_28586084	228	chr33	28585687	ENSCAFT00000018884	ENSCAFP00000017500	R	36	K	478584	benign	N
Contig113_chr5_16682954_16684491	688	chr5	16683641	ENSCAFT00000018997	ENSCAFP00000017606	F	41	L	489360	benign	N
Contig36_chr28_31449413_31452160	2111	chr28	31451506	ENSCAFT00000019041	ENSCAFP00000017650	P	252	H	477834	benign	cfa04144=Endocytosis
Contig80_chr3_55628026_55628800	392	chr3	55628403	ENSCAFT00000019070	ENSCAFP00000017677	R	805	K	403913	benign	cfa00480=Glutathione metabolism.cfa01100=Metabolic pathways.cfa04614=Renin-angiotensin system.cfa04640=Hematopoietic cell lineage
Contig99_chr7_11816365_11819255	806	chr7	11817201	ENSCAFT00000019101	ENSCAFP00000017707	C	305	G	490276	benign	N
Contig114_chr4_12744102_12745318	148	chr4	12744256	ENSCAFT00000019279	ENSCAFP00000017880	I	700	V	U	benign	N
Contig82_chr7_13056757_13058281	974	chr7	13057742	ENSCAFT00000019316	ENSCAFP00000017915	S	283	N	609933	benign	cfa00564=Glycerophospholipid metabolism
Contig280_chr25_51367477_51367885	70	chr25	51367542	ENSCAFT00000019610	ENSCAFP00000018191	S	97	L	U	benign	N
Contig35_chr20_43508791_43509352	460	chr20	43509254	ENSCAFT00000019627	ENSCAFP00000018204	V	77	A	608455	benign	cfa00190=Oxidative phosphorylation.cfa01100=Metabolic pathways.cfa04260=Cardiac muscle contraction.cfa05010=Alzheimer's disease.cfa05012=Parkinson's disease.cfa05016=Huntington's disease
Contig36_chr20_43509362_43510980	1484	chr20	43510860	ENSCAFT00000019627	ENSCAFP00000018204	D	181	N	608455	benign	cfa00190=Oxidative phosphorylation.cfa01100=Metabolic pathways.cfa04260=Cardiac muscle contraction.cfa05010=Alzheimer's disease.cfa05012=Parkinson's disease.cfa05016=Huntington's disease
Contig59_chr25_51807653_51809044	1064	chr25	51808739	ENSCAFT00000019760	ENSCAFP00000018330	R	235	K	U	benign	N
Contig96_chr36_17712997_17714068	556	chr36	17713559	ENSCAFT00000019807	ENSCAFP00000018374	T	423	I	478789	benign	N
Contig163_chr28_34927368_34929275	1128	chr28	34928486	ENSCAFT00000019866	ENSCAFP00000018425	A	2659	T	477850	benign	N
Contig74_chr33_31230250_31230874	246	chr33	31230493	ENSCAFT00000019938	ENSCAFP00000018492	G	113	S	488016	probably damaging	N
Contig130_chr7_15553315_15558308	3186	chr7	15556497	ENSCAFT00000020009	ENSCAFP00000018561	K	1513	N	U	benign	N
Contig160_chr2_76816412_76817166	354	chr2	76816779	ENSCAFT00000020143	ENSCAFP00000018683	I	190	V	478173	benign	N
Contig219_chr33_31871568_31871771	81	chr33	31871646	ENSCAFT00000020195	ENSCAFP00000018733	N	346	H	U	probably damaging	N
Contig254_chr24_50001599_50001992	151	chr24	50001767	ENSCAFT00000020266	ENSCAFP00000018803	R	239	Q	U	benign	N
Contig40_chr37_15283702_15285945	1908	chr37	15285621	ENSCAFT00000020408	ENSCAFP00000018937	A	809	G	U	unknown	N
Contig59_chr20_43702094_43703358	450	chr20	43702540	ENSCAFT00000020438	ENSCAFP00000018965	S	217	A	U	benign	N
Contig75_chr3_57465650_57466327	377	chr3	57466017	ENSCAFT00000020863	ENSCAFP00000019371	L	205	F	609716	probably damaging	N
Contig155_chr2_79195879_79199423	2014	chr2	79197892	ENSCAFT00000021154	ENSCAFP00000019645	G	549	S	U	benign	N
Contig155_chr2_79195879_79199423	3136	chr2	79199014	ENSCAFT00000021154	ENSCAFP00000019645	R	923	C	U	probably damaging	N
Contig59_chr5_19784971_19787384	1310	chr5	19786293	ENSCAFT00000021222	ENSCAFP00000019707	V	171	I	479428.489393	benign	cfa03320=PPAR signaling pathway
Contig41_chr30_14304605_14305465	206	chr30	14304816	ENSCAFT00000021612	ENSCAFP00000020069	A	157	G	U	benign	N
Contig47_chr20_45043804_45044476	317	chr20	45044117	ENSCAFT00000021659	ENSCAFP00000020114	V	281	I	609323	benign	N
Contig46_chr4_22849549_22849829	123	chr4	22849673	ENSCAFT00000021752	ENSCAFP00000020204	V	646	M	U	probably damaging	N
Contig141_chr7_22360980_22361690	242	chr7	22361233	ENSCAFT00000021777	ENSCAFP00000020227	K	1862	R	U	unknown	N
Contig59_chr30_14758622_14760653	1186	chr30	14759817	ENSCAFT00000021792	ENSCAFP00000020241	S	284	R	609256	benign	N
Contig57_chr27_39696388_39698349	1026	chr27	39697428	ENSCAFT00000021846	ENSCAFP00000020293	Q	588	R	477699	benign	cfa04610=Complement and coagulation cascades
Contig83_chr27_40151814_40153141	738	chr27	40152551	ENSCAFT00000022064	ENSCAFP00000020490	S	191	R	477702	benign	N
Contig105_chr6_11901733_11904968	406	chr6	11902145	ENSCAFT00000022289	ENSCAFP00000020701	Y	55	H	479732	probably damaging	cfa04621=NOD-like receptor signaling pathway
Contig43_chr36_25298890_25299602	235	chr36	25299132	ENSCAFT00000022319	ENSCAFP00000020728	E	11731	K	610299.610339	unknown	N
Contig3_chr36_25193150_25202641	2802	chr36	25195983	ENSCAFT00000022319	ENSCAFP00000020728	I	30137	V	610299.610339	benign	N
Contig585_chr3_61201332_61201904	139	chr3	61201468	ENSCAFT00000022529	ENSCAFP00000020918	L	97	V	479067	benign	cfa00071=Fatty acid metabolism.cfa03320=PPAR signaling pathway.cfa04920=Adipocytokine signaling pathway
Contig1_chr20_46714929_46715937	434	chr20	46715327	ENSCAFT00000022571	ENSCAFP00000020958	A	18	P	484804	unknown	N
Contig7_chr8_29376780_29378260	158	chr8	29376937	ENSCAFT00000022576	ENSCAFP00000020962	T	852	A	490678	benign	N
Contig74_chr8_29656170_29657212	595	chr8	29656776	ENSCAFT00000022697	ENSCAFP00000021080	E	974	K	490682	possibly damaging	cfa04010=MAPK signaling pathway.cfa04012=ErbB signaling pathway.cfa04062=Chemokine signaling pathway.cfa04320=Dorso-ventral axis formation.cfa04510=Focal adhesion.cfa04540=Gap junction.cfa04630=Jak-STAT signaling pathway.cfa04650=Natural killer cell mediated cytotoxicity.cfa04660=T cell receptor signaling pathway.cfa04662=B cell receptor signaling pathway.cfa04664=Fc epsilon RI signaling pathway.cfa04722=Neurotrophin signaling pathway.cfa04810=Regulation of actin cytoskeleton.cfa04910=Insulin signaling pathway.cfa04912=GnRH signaling pathway.cfa05160=Hepatitis C.cfa05200=Pathways in cancer.cfa05211=Renal cell carcinoma.cfa05213=Endometrial cancer.cfa05214=Glioma.cfa05215=Prostate cancer.cfa05220=Chronic myeloid leukemia.cfa05221=Acute myeloid leukemia.cfa05223=Non-small cell lung cancer
Contig45_chr4_25273541_25274402	608	chr4	25274121	ENSCAFT00000022760	ENSCAFP00000021140	S	30	F	479239	probably damaging	cfa04360=Axon guidance
Contig96_chr37_26111249_26111450	108	chr37	26111364	ENSCAFT00000022884	ENSCAFP00000021256	K	260	R	478902	benign	cfa03450=Non-homologous end-joining
Contig196_chr3_62434637_62435063	203	chr3	62434823	ENSCAFT00000022915	ENSCAFP00000021284	L	174	P	488785	benign	N
Contig15_chr6_12238116_12239737	1287	chr6	12239420	ENSCAFT00000022961	ENSCAFP00000021328	E	165	K	479735	benign	N
Contig175_chr5_27267391_27267870	57	chr5	27267451	ENSCAFT00000023032	ENSCAFP00000021395	N	1094	S	479450	benign	cfa04110=Cell cycle.cfa04115=p53 signaling pathway.cfa04210=Apoptosis.cfa05166=HTLV-I infection
Contig110_chr20_47192181_47193618	93	chr20	47192262	ENSCAFT00000023054	ENSCAFP00000021407	A	308	P	484814	probably damaging	N
Contig9_chr4_26730063_26730585	245	chr4	26730316	ENSCAFT00000023087	ENSCAFP00000021437	E	153	D	489044	benign	N
Contig1_chr34_35420831_35421658	73	chr34	35420908	ENSCAFT00000023111	ENSCAFP00000021457	V	251	I	488144	benign	N
Contig199_chr2_79696091_79697603	751	chr2	79696840	ENSCAFT00000023253	ENSCAFP00000021593	D	54	A	U	possibly damaging	N
Contig146_chrX_38946913_38947473	307	chrX	38947225	ENSCAFT00000023268	ENSCAFP00000021608	L	160	V	612457	possibly damaging	N
Contig63_chr9_23532151_23533554	1297	chr9	23533421	ENSCAFT00000023438	ENSCAFP00000021767	Q	279	R	490958	benign	N
Contig89_chr5_32060784_32061151	293	chr5	32061079	ENSCAFT00000023913	ENSCAFP00000022199	W	106	*	489430	probably damaging	N
Contig15_chr3_65640843_65642155	1100	chr3	65641942	ENSCAFT00000023933	ENSCAFP00000022218	V	383	A	479080	benign	N
Contig49_chr26_33571748_33572620	689	chr26	33572452	ENSCAFT00000024062	ENSCAFP00000022339	R	478	W	486440	benign	N
Contig96_chr20_48055741_48057197	524	chr20	48056259	ENSCAFT00000024100	ENSCAFP00000022374	R	172	Q	U	benign	N
Contig104_chr20_48062263_48062546	210	chr20	48062492	ENSCAFT00000024100	ENSCAFP00000022374	V	775	G	U	probably damaging	N
Contig33_chr37_28794567_28796956	2144	chr37	28796718	ENSCAFT00000024137	ENSCAFP00000022408	E	279	Q	488536	benign	N
Contig24_chr7_32005266_32005660	212	chr7	32005479	ENSCAFT00000024154	ENSCAFP00000022424	T	92	M	U	probably damaging	N
Contig174_chr18_56896461_56897594	274	chr18	56896734	ENSCAFT00000024637	ENSCAFP00000022858	V	157	L	483779	benign	cfa04130=SNARE interactions in vesicular transport
Contig55_chr20_48811642_48812027	299	chr20	48811941	ENSCAFT00000024761	ENSCAFP00000022970	H	993	R	476678	benign	N
Contig220_chr18_56925351_56927006	920	chr18	56926246	ENSCAFT00000024787	ENSCAFP00000022995	P	420	Q	476051	possibly damaging	cfa03022=Basal transcription factors.cfa05168=Herpes simplex infection
Contig12_chr8_39044824_39045409	359	chr8	39045181	ENSCAFT00000024804	ENSCAFP00000023011	I	280	T	612894	possibly damaging	N
Contig23_chr3_72567678_72570858	1313	chr3	72568976	ENSCAFT00000024846	ENSCAFP00000023051	L	298	P	488826	benign	N
Contig190_chr7_35896301_35896811	232	chr7	35896528	ENSCAFT00000024892	ENSCAFP00000023095	R	3	L	480092	unknown	cfa00020=Citrate cycle (TCA cycle).cfa01100=Metabolic pathways.cfa05200=Pathways in cancer.cfa05211=Renal cell carcinoma
Contig119_chr20_49114009_49114654	266	chr20	49114270	ENSCAFT00000024934	ENSCAFP00000023135	F	339	L	484849	benign	N
Contig47_chr8_41487304_41487682	210	chr8	41487515	ENSCAFT00000025088	ENSCAFP00000023286	S	1743	L	490729	possibly damaging	N
Contig67_chr2_84099157_84100880	345	chr2	84099493	ENSCAFT00000025109	ENSCAFP00000023307	I	60	L	U	benign	N
Contig33_chr20_49727730_49730958	2192	chr20	49729935	ENSCAFT00000025308	ENSCAFP00000023495	T	448	R	U	probably damaging	N
Contig33_chr20_49727730_49730958	2907	chr20	49730606	ENSCAFT00000025308	ENSCAFP00000023495	W	493	L	U	benign	N
Contig93_chr8_42181027_42183022	694	chr8	42181716	ENSCAFT00000025462	ENSCAFP00000023641	L	782	P	U	benign	N
Contig131_chrX_44937490_44940040	950	chrX	44938456	ENSCAFT00000025663	ENSCAFP00000023835	V	120	M	491894	benign	N
Contig100_chrX_44915404_44918232	1832	chrX	44917224	ENSCAFT00000025663	ENSCAFP00000023835	R	1212	Q	491894	benign	N
Contig100_chrX_44915404_44918232	920	chrX	44916331	ENSCAFT00000025663	ENSCAFP00000023835	L	1377	V	491894	benign	N
Contig123_chr9_26132942_26133532	310	chr9	26133253	ENSCAFT00000025948	ENSCAFP00000024090	I	232	V	491022	benign	N
Contig34_chr6_17772839_17773548	489	chr6	17773329	ENSCAFT00000026008	ENSCAFP00000024146	E	377	Q	U	benign	N
Contig382_chr7_43383655_43383893	190	chr7	43383854	ENSCAFT00000026053	ENSCAFP00000024188	R	123	C	U	possibly damaging	N
Contig163_chr2_87404548_87404792	132	chr2	87404673	ENSCAFT00000026251	ENSCAFP00000024378	D	239	N	U	benign	N
Contig15_chr3_91850893_91851323	75	chr3	91850967	ENSCAFT00000026343	ENSCAFP00000024465	S	722	N	595148	benign	cfa04360=Axon guidance
Contig141_chr7_44385686_44386047	166	chr7	44385857	ENSCAFT00000026393	ENSCAFP00000024510	L	166	P	490412	benign	cfa04810=Regulation of actin cytoskeleton
Contig161_chr2_87840986_87841705	540	chr2	87841516	ENSCAFT00000026485	ENSCAFP00000024598	F	678	C	478233	probably damaging	cfa03018=RNA degradation
Contig177_chr9_27497479_27498192	354	chr9	27497831	ENSCAFT00000026613	ENSCAFP00000024719	A	175	V	491046	possibly damaging	N
Contig162_chr6_20156115_20157725	81	chr6	20156197	ENSCAFT00000026687	ENSCAFP00000024793	T	702	M	489923.489924.607168	benign	N
Contig8_chr9_28287278_28288276	469	chr9	28287755	ENSCAFT00000026707	ENSCAFP00000024813	A	75	P	491060	benign	N
Contig166_chr7_45276673_45277595	235	chr7	45276916	ENSCAFT00000026881	ENSCAFP00000024984	V	525	I	490428	benign	N
Contig16_chr8_51223078_51223662	481	chr8	51223563	ENSCAFT00000026967	ENSCAFP00000025070	R	869	Q	490790	benign	N
Contig65_chr9_29792446_29793465	893	chr9	29793341	ENSCAFT00000027073	ENSCAFP00000025173	S	81	A	491082	benign	N
Contig175_chr6_30926774_30927470	446	chr6	30927229	ENSCAFT00000027269	ENSCAFP00000025361	S	663	T	403453	benign	cfa02010=ABC transporters.cfa04977=Vitamin digestion and absorption
Contig45_chr30_33024389_33025619	471	chr30	33024857	ENSCAFT00000027320	ENSCAFP00000025407	G	986	A	487608	benign	N
Contig60_chr20_53087461_53088013	184	chr20	53087649	ENSCAFT00000027519	ENSCAFP00000025591	S	556	L	611163	benign	N
Contig98_chr5_37073086_37073674	378	chr5	37073467	ENSCAFT00000027596	ENSCAFP00000025664	V	38	M	479499	probably damaging	cfa04130=SNARE interactions in vesicular transport
Contig64_chr9_36235086_36235751	475	chr9	36235563	ENSCAFT00000027673	ENSCAFP00000025737	D	260	E	491111	benign	cfa04970=Salivary secretion
Contig72_chr30_35330469_35330831	236	chr30	35330709	ENSCAFT00000027712	ENSCAFP00000025770	G	386	C	478353	probably damaging	cfa04510=Focal adhesion.cfa04512=ECM-receptor interaction.cfa04810=Regulation of actin cytoskeleton.cfa05410=Hypertrophic cardiomyopathy (HCM).cfa05412=Arrhythmogenic right ventricular cardiomyopathy (ARVC).cfa05414=Dilated cardiomyopathy
Contig12_chr8_66066327_66066629	89	chr8	66066402	ENSCAFT00000027927	ENSCAFP00000025970	K	158	R	490836	benign	N
Contig212_chr8_66173086_66174259	622	chr8	66173712	ENSCAFT00000027950	ENSCAFP00000025993	K	114	Q	480421	benign	N
Contig176_chr7_48083671_48084458	311	chr7	48083983	ENSCAFT00000027972	ENSCAFP00000026015	R	128	H	480148	probably damaging	N
Contig3_chr4_58820541_58821952	265	chr4	58820806	ENSCAFT00000027979	ENSCAFP00000026022	A	31	T	489166	benign	N
Contig24_chr7_48238665_48239174	383	chr7	48239049	ENSCAFT00000028007	ENSCAFP00000026049	T	227	M	480151	probably damaging	N
Contig25_chr6_26340448_26341519	657	chr6	26341104	ENSCAFT00000028115	ENSCAFP00000026155	S	128	L	479811	possibly damaging	N
Contig212_chr5_38871122_38871621	302	chr5	38871429	ENSCAFT00000028231	ENSCAFP00000026253	P	2265	L	489507	benign	N
Contig147_chr6_27310627_27310983	100	chr6	27310719	ENSCAFT00000028327	ENSCAFP00000026344	V	154	A	U	benign	N
Contig160_chr6_27318582_27318861	67	chr6	27318647	ENSCAFT00000028327	ENSCAFP00000026344	K	325	R	U	benign	N
Contig18_chr4_61023435_61026038	385	chr4	61023825	ENSCAFT00000028363	ENSCAFP00000026377	P	4110	L	479323	benign	N
Contig162_chr30_40685605_40687049	343	chr30	40685956	ENSCAFT00000028463	ENSCAFP00000026472	A	416	P	487646	benign	N
Contig68_chr20_54017481_54018354	221	chr20	54017705	ENSCAFT00000028500	ENSCAFP00000026509	W	539	R	U	benign	N
Contig50_chr7_59076761_59079381	2353	chr7	59079104	ENSCAFT00000028551	ENSCAFP00000026557	V	1487	I	490492	benign	N
Contig51_chr7_59079274_59084588	2611	chr7	59081905	ENSCAFT00000028551	ENSCAFP00000026557	A	575	V	490492	benign	N
Contig3_chr20_54855789_54856135	37	chr20	54855833	ENSCAFT00000028813	ENSCAFP00000026796	F	6015	S	U	unknown	N
Contig157_chr5_43472186_43472528	168	chr5	43472353	ENSCAFT00000028826	ENSCAFP00000026807	R	355	Q	489526	benign	cfa00010=Glycolysis / Gluconeogenesis.cfa00340=Histidine metabolism.cfa00350=Tyrosine metabolism.cfa00360=Phenylalanine metabolism.cfa00410=beta-Alanine metabolism.cfa00980=Metabolism of xenobiotics by cytochrome P450.cfa00982=Drug metabolism - cytochrome P450.cfa01100=Metabolic pathways
Contig80_chr20_55281094_55281971	129	chr20	55281228	ENSCAFT00000028936	ENSCAFP00000026914	T	931	A	U	benign	N
Contig214_chr8_74493164_74493474	188	chr8	74493346	ENSCAFT00000029054	ENSCAFP00000027017	R	94	C	U	probably damaging	N
Contig259_chr20_55571618_55572503	186	chr20	55571803	ENSCAFT00000029100	ENSCAFP00000027059	K	526	Q	485001	benign	N
Contig180_chr9_41668066_41668716	357	chr9	41668451	ENSCAFT00000029122	ENSCAFP00000027081	E	990	D	491145	benign	cfa03410=Base excision repair
Contig61_chr4_63087183_63089623	491	chr4	63087672	ENSCAFT00000029130	ENSCAFP00000027089	A	20	S	U	benign	N
Contig261_chrX_94412915_94414298	488	chrX	94413396	ENSCAFT00000029188	ENSCAFP00000027142	D	329	E	U	unknown	N
Contig58_chr4_70221679_70223505	1749	chr4	70223432	ENSCAFT00000029501	ENSCAFP00000027423	T	324	S	403721	benign	cfa04060=Cytokine-cytokine receptor interaction.cfa04080=Neuroactive ligand-receptor interaction.cfa04630=Jak-STAT signaling pathway
Contig21_chr7_77985141_77986170	827	chr7	77985962	ENSCAFT00000029651	ENSCAFP00000027557	A	855	S	490545	benign	N
Contig93_chrX_104176429_104177974	811	chrX	104177246	ENSCAFT00000029709	ENSCAFP00000027610	T	719	M	492128	benign	cfa03008=Ribosome biogenesis in eukaryotes
Contig175_chr9_46116277_46118268	1090	chr9	46117366	ENSCAFT00000029722	ENSCAFP00000027622	Q	693	H	U	benign	N
Contig134_chr4_76495667_76496825	860	chr4	76496507	ENSCAFT00000029827	ENSCAFP00000027720	I	113	V	612589	benign	cfa00250=Alanine, aspartate and glutamate metabolism.cfa00260=Glycine, serine and threonine metabolism.cfa01100=Metabolic pathways
Contig247_chr6_31967574_31967796	158	chr6	31967732	ENSCAFT00000029875	ENSCAFP00000027765	P	750	T	489999	benign	N
Contig6_chr7_81650872_81657348	3786	chr7	81654636	ENSCAFT00000030050	ENSCAFP00000027927	S	501	C	480218	benign	N
Contig122_chr5_57147596_57148457	360	chr5	57147964	ENSCAFT00000030140	ENSCAFP00000028007	T	713	I	479558	benign	N
Contig83_chr20_58039274_58039724	380	chr20	58039649	ENSCAFT00000030192	ENSCAFP00000028056	E	142	K	611866	benign	N
Contig42_chr5_58023274_58024296	585	chr5	58023845	ENSCAFT00000030282	ENSCAFP00000028135	V	415	A	489580	benign	N
Contig248_chr20_58217741_58219717	751	chr20	58218495	ENSCAFT00000030285	ENSCAFP00000028138	G	278	S	485038	unknown	N
Contig127_chr6_39501489_39501966	83	chr6	39501576	ENSCAFT00000030381	ENSCAFP00000028228	N	155	S	490020	benign	N
Contig123_chr6_39499974_39501056	816	chr6	39500798	ENSCAFT00000030381	ENSCAFP00000028228	A	195	P	490020	benign	N
Contig247_chr6_39576694_39577607	493	chr6	39577171	ENSCAFT00000030386	ENSCAFP00000028233	S	745	N	490021	benign	N
Contig6_chr9_50725202_50725646	143	chr9	50725344	ENSCAFT00000030726	ENSCAFP00000028560	M	12	T	491218	benign	N
Contig221_chr6_41879771_41881379	766	chr6	41880519	ENSCAFT00000030883	ENSCAFP00000028717	A	184	T	606755	benign	N
Contig231_chr5_60474911_60475630	279	chr5	60475186	ENSCAFT00000030960	ENSCAFP00000028794	C	505	Y	489618	possibly damaging	N
Contig99_chr5_63306202_63308496	2063	chr5	63308224	ENSCAFT00000031146	ENSCAFP00000028978	A	421	V	U	unknown	N
Contig245_chr5_66149146_66149848	349	chr5	66149499	ENSCAFT00000031407	ENSCAFP00000029234	R	207	Q	479601	benign	cfa00760=Nicotinate and nicotinamide metabolism.cfa01100=Metabolic pathways
Contig305_chr5_67253589_67254394	375	chr5	67253954	ENSCAFT00000031570	ENSCAFP00000029391	R	203	Q	U	possibly damaging	N
Contig94_chr9_56873843_56875505	1578	chr9	56875408	ENSCAFT00000031743	ENSCAFP00000029555	P	2937	S	U	benign	N
Contig107_chr5_71317862_71318113	71	chr5	71317944	ENSCAFT00000031781	ENSCAFP00000029590	M	281	V	U	benign	N
Contig134_chr9_57426140_57427208	236	chr9	57426380	ENSCAFT00000031798	ENSCAFP00000029606	V	89	I	480698	benign	cfa00590=Arachidonic acid metabolism.cfa01100=Metabolic pathways
Contig60_chr12_5631507_5632392	818	chr12	5632313	ENSCAFT00000031814	ENSCAFP00000029621	Y	1697	C	481734	unknown	cfa04510=Focal adhesion.cfa04512=ECM-receptor interaction.cfa04974=Protein digestion and absorption.cfa05146=Amoebiasis
Contig132_chr5_73710776_73711271	149	chr5	73710927	ENSCAFT00000031848	ENSCAFP00000029653	T	1323	M	489696	probably damaging	N
Contig39_chr9_59278364_59279024	398	chr9	59278757	ENSCAFT00000032068	ENSCAFP00000029863	A	957	T	480718	benign	N
Contig177_chr9_61212763_61213621	700	chr9	61213430	ENSCAFT00000032171	ENSCAFP00000029958	D	79	N	U	benign	N
Contig67_chr6_62507717_62510152	1055	chr6	62508787	ENSCAFT00000032186	ENSCAFP00000029972	I	212	M	479959	probably damaging	cfa00380=Tryptophan metabolism.cfa00450=Selenocompound metabolism.cfa01100=Metabolic pathways
Contig66_chr6_64570039_64570630	325	chr6	64570365	ENSCAFT00000032239	ENSCAFP00000030024	A	862	G	479964	benign	cfa04740=Olfactory transduction.cfa04972=Pancreatic secretion
Contig22_chr6_64809414_64810661	626	chr6	64810027	ENSCAFT00000032269	ENSCAFP00000030052	Q	559	K	490179	benign	N
Contig50_chr5_85052459_85052865	55	chr5	85052515	ENSCAFT00000032431	ENSCAFP00000030201	S	32	G	479688	benign	N
Contig25_chr5_85095840_85098495	1627	chr5	85097474	ENSCAFT00000032433	ENSCAFP00000030203	F	681	S	U	benign	N
Contig25_chr5_85480673_85480982	186	chr5	85480860	ENSCAFT00000032493	ENSCAFP00000030260	A	180	T	610026	possibly damaging	cfa05010=Alzheimer's disease
Contig19_chr5_24601128_24602241	685	chr5	24601813	ENSCAFT00000035141	ENSCAFP00000030364	T	695	S	U	benign	N
Contig59_chr26_11519273_11520242	659	chr26	11519937	ENSCAFT00000035276	ENSCAFP00000030520	P	160	L	403557	probably damaging	cfa03015=mRNA surveillance pathway.cfa04114=Oocyte meiosis.cfa04270=Vascular smooth muscle contraction.cfa04510=Focal adhesion.cfa04720=Long-term potentiation.cfa04728=Dopaminergic synapse.cfa04810=Regulation of actin cytoskeleton.cfa04910=Insulin signaling pathway.cfa05168=Herpes simplex infection
Contig27_chr12_23130802_23131771	353	chr12	23131154	ENSCAFT00000035307	ENSCAFP00000030552	V	565	M	474935	probably damaging	N
Contig31_chr1_8052327_8053606	234	chr1	8052570	ENSCAFT00000035442	ENSCAFP00000030703	C	153	S	U	possibly damaging	N
Contig59_chr20_40539078_40540678	1223	chr20	40540302	ENSCAFT00000035532	ENSCAFP00000030804	H	285	R	403502	benign	cfa04620=Toll-like receptor signaling pathway.cfa05142=Chagas disease (American trypanosomiasis).cfa05143=African trypanosomiasis.cfa05144=Malaria.cfa05152=Tuberculosis.cfa05162=Measles.cfa05168=Herpes simplex infection
Contig152_chr6_25356961_25358151	701	chr6	25357665	ENSCAFT00000035750	ENSCAFP00000031044	P	479	S	608555	benign	cfa04142=Lysosome
Contig18_chr9_58576258_58576773	215	chr9	58576474	ENSCAFT00000035914	ENSCAFP00000031224	K	118	E	480706	benign	N
Contig8_chr15_38734005_38734403	242	chr15	38734244	ENSCAFT00000035916	ENSCAFP00000031226	A	237	V	611996	possibly damaging	N
Contig76_chr3_30625909_30626247	159	chr3	30626069	ENSCAFT00000036198	ENSCAFP00000031549	T	135	S	479171	benign	cfa00260=Glycine, serine and threonine metabolism.cfa00270=Cysteine and methionine metabolism.cfa01100=Metabolic pathways
Contig86_chr37_14528768_14530343	873	chr37	14529628	ENSCAFT00000036570	ENSCAFP00000031969	V	738	D	478875.609202	possibly damaging	cfa04060=Cytokine-cytokine receptor interaction.cfa04350=TGF-beta signaling pathway
Contig9_chr5_54124181_54125739	1134	chr5	54125291	ENSCAFT00000036640	ENSCAFP00000032043	A	187	T	610286	benign	N
Contig107_chr9_8990420_8991676	1178	chr9	8991591	ENSCAFT00000036774	ENSCAFP00000032186	T	55	M	483288	benign	N
Contig47_chr12_20319418_20320775	1212	chr12	20320622	ENSCAFT00000036825	ENSCAFP00000032241	K	606	T	474930	benign	cfa00280=Valine, leucine and isoleucine degradation.cfa00630=Glyoxylate and dicarboxylate metabolism.cfa00640=Propanoate metabolism.cfa01100=Metabolic pathways
Contig4_chr2_45195542_45196115	233	chr2	45195785	ENSCAFT00000037022	ENSCAFP00000032463	D	833	N	478055	possibly damaging	N
Contig8_chr8_77227029_77227651	339	chr8	77227366	ENSCAFT00000037096	ENSCAFP00000032544	T	61	A	490895.612602	benign	cfa04020=Calcium signaling pathway.cfa04145=Phagosome.cfa04640=Hematopoietic cell lineage.cfa04650=Natural killer cell mediated cytotoxicity.cfa04662=B cell receptor signaling pathway.cfa04664=Fc epsilon RI signaling pathway.cfa04666=Fc gamma R-mediated phagocytosis.cfa04672=Intestinal immune network for IgA production.cfa05140=Leishmaniasis.cfa05143=African trypanosomiasis.cfa05146=Amoebiasis.cfa05150=Staphylococcus aureus infection.cfa05152=Tuberculosis.cfa05162=Measles.cfa05310=Asthma.cfa05320=Autoimmune thyroid disease.cfa05322=Systemic lupus erythematosus.cfa05323=Rheumatoid arthritis.cfa05330=Allograft rejection.cfa05340=Primary immunodeficiency.cfa05414=Dilated cardiomyopathy.cfa05416=Viral myocarditis
Contig2_chr7_60049092_60051693	266	chr7	60049361	ENSCAFT00000038176	ENSCAFP00000033857	T	195	M	U	probably damaging	N
Contig31_chr30_24179816_24187402	4867	chr30	24184686	ENSCAFT00000038211	ENSCAFP00000033897	G	103	S	U	benign	N
Contig9_chr27_48250956_48251793	192	chr27	48251161	ENSCAFT00000038256	ENSCAFP00000033944	T	166	M	477739	probably damaging	N
Contig45_chr27_43537046_43537944	568	chr27	43537599	ENSCAFT00000038301	ENSCAFP00000033996	M	69	I	611773	benign	cfa04010=MAPK signaling pathway.cfa04810=Regulation of actin cytoskeleton.cfa05200=Pathways in cancer.cfa05218=Melanoma
Contig133_chr18_28371600_28372547	83	chr18	28371695	ENSCAFT00000038383	ENSCAFP00000034090	L	102	Q	475933	probably damaging	N
Contig11_chr28_8532951_8533892	511	chr28	8533462	ENSCAFT00000038937	ENSCAFP00000034728	R	19	C	477763	probably damaging	cfa03008=Ribosome biogenesis in eukaryotes.cfa03013=RNA transport
Contig1_chr14_5733966_5735336	783	chr14	5734754	ENSCAFT00000039094	ENSCAFP00000034905	A	166	T	U	benign	N
Contig48_chr27_6001075_6001818	392	chr27	6001478	ENSCAFT00000039109	ENSCAFP00000034919	R	103	H	U	probably damaging	N
Contig40_chr11_43589173_43590288	973	chr11	43590138	ENSCAFT00000039148	ENSCAFP00000034962	R	1617	P	481557	benign	N
Contig1_chr14_30424688_30425258	179	chr14	30424861	ENSCAFT00000039390	ENSCAFP00000035239	T	648	I	475245	benign	cfa04666=Fc gamma R-mediated phagocytosis.cfa04810=Regulation of actin cytoskeleton
Contig58_chr8_7461111_7462065	323	chr8	7461423	ENSCAFT00000039451	ENSCAFP00000035309	L	112	F	U	benign	N
Contig1_chr25_43094809_43095852	908	chr25	43095708	ENSCAFT00000039609	ENSCAFP00000035483	W	18	G	U	unknown	N
Contig114_chr25_43076436_43076800	141	chr25	43076581	ENSCAFT00000039609	ENSCAFP00000035483	S	45	C	U	unknown	N